Whitepaper: Hidradenitis suppurativa - From White Space to Benchmark Space
HS is no longer a category defined by unmet need. With 3 approved biologics, an oral JAK1 inhibitor setting a new depth-of-response bar, and MoonLake's Phase 3 data imminent, the ...